Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

Use of the ASCO Guidelines App may provide credit for up to 2 MIPS Improvement Activities! With this app you can search selected ASCO Clinical Practice Guidelines with the tap of your finger. Expert recommendations, algorithms, and calculators help make decisions at the point-of-care.
The Clinical Practice Guidelines Committee (CPGC) is conducting a survey to solicit topics for clinical practice guideline development, and the CPGC would like to invite members of other ASCO Committees to participate in the process. The CPGC has delegated the identification and prioritization of guideline topics to their Guideline Advisory Groups (AGs). The AGs will consider topics suggested by the ASCO membership when revisiting current priorities.
ASCO will be hosting a live webinar on May 21st at 12:00 PM ET, with Dr. Alejandro Lazo-Langner and Dr. Benjamin Djulbegovic on the recent guideline update on Management of Cancer-Associated Anemia With ESAs. Register now.
ASCO recently posted the following guidelines: Management of Cancer-associated Anemia with Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer
The Centers for Disease Control and Prevention (CDC) issued a key clarification on its Guideline for Prescribing Opioids for Chronic Pain. The clarification comes as a result of a collaborative effort by ASCO, the American Society of Hematology (ASH), CDC, and the National Comprehensive Cancer Network (NCCN) to clarify CDC’s opioid prescribing guideline to ensure appropriate implementation for people with cancer, cancer survivors, and patients with sickle cell disease.
Here are new ASCO Guidelines publications posted in March:  Adjuvant Therapy for Resected Biliary Tract Cancer Guideline Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors CNS Endorsement
ASCO invites interested stakeholders to submit comments on draft guideline recommendations on Management of Osteoporosis in Survivors of Adult Cancers between February 7 - February 21. This open comment process provides greater transparency in the guideline development process and the opportunity for key stakeholders to provide feedback before the document’s finalization and publication. Participate now.  
ASCO recently published standards on the safe handling of hazardous drugs in the Journal of Clinical Oncology. ASCO’s standards largely endorse the practices recommended by other stakeholder groups for safely handling hazardous drugs but offer alternatives in areas where more research is needed to identify evidence-based safety measures.